Skip to main content

Advertisement

Table 2 Number of patients who achieved target blood glucose levels after 21 days of dietary treatment

From: The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial

  Ma-Pi 2 diet (n. 25) Control diet (n. 26)   95% CI*
Fasting blood glucose (target value ≤ 110 mg/dl) n (%) n (%) Difference (%) LL UL
Target achievement** 19 (100) 9 (45) 55.00 33.20 76.80
Target maintenance** 6 (100) 5 (83.33) 16.67 −13.15 46.49
Post-prandial blood glucose (target value ≤ 140 mg/dl)      
Target achievement 11 (100) 8 (53.33) 46.67 21.42 71.91
Target maintenance 14 (100) 9 (81.82) 18.18 −4.61 40.97
  1. *McNemar test. Coefficients are statistically significant when the 95% CI’s does not include zero.
  2. **The percentage of patients that achieved the glycemic target level (both fasting and 2-h after lunch capillary glucose) between T0 and T21 and the percentage of patients that maintained the glycemic target level (both fasting and 2-h after lunch capillary glucose) between T0 and T21, in the Ma-Pi 2 group compared with the control group.